Summary
Basement membrane anionic sites, thought to be responsible for charge selective permeability barriers, were investigated in retinal, endoneurial, and muscle capillary basement membranes and in Bruch's membrane of diabetic, and age- and sex-matched non-diabetic BB-rats using an ultrastructural quantitative histochemical technique. Six months of diabetes was associated with significant basement membrane thickening which was linearly related to a decrease in anionic site density suggesting a relative loss of proteoglycans. Calculation of anionic sites per unit length of basement membrane, reflecting their absolute number, revealed a significant loss in basement membrane, constituting part of normal blood-tissue barrier systems such as retinal and endoneurial capillary basement membranes, and the basement membrane of the retinal pigment epithelium. The absolute number of anionic sites in normally permeable microvessels, such as those of muscle and choriocapillaries, was unaltered by diabetes. We conclude that this specific loss of anionic sites in basement membranes of tissues affected by chronic diabetic complications may in part be responsible for permeability abnormalities seen in these tissues.
Article PDF
Similar content being viewed by others
References
Williamson JR, Tilton RG, Chang K, Kilo C (1988) Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diab Metabol Review 4: 339–370
Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C (1987) Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes: prevention by aldose reductase inhibition and castration. Diabetes 36: 813–821
Chakrabarti S, Sima AAF (1989) Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Diabetes 38: 1181–1186
Caldwell RB, Slapnick SM, McLaughlin BJ (1986) Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes. Invest Ophthalmol Vis Sci 27: 1691–1697
Schleicher E, Nerlich A, Gerbitz K-D (1988) Pathobiochemical aspects of diabetic nephropathy. Klin Wochenschr 66: 873–882
Rechthand E, Smith QR, Latker CH, Rapaport SI (1987) Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus. J Neuropath Exp Neurol 46: 302–314
Rohrbach DH, Martin GR (1982) Structure of basement membrane in normal and diabetic tissue. Ann New York Acad Sci 401: 203–209
Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML (1983) Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci 80: 2272–2275
Parthasarathy N, Spiro RG (1982) Effect of diabetes on the glycosaminoglycan component of human glomerular basement membrane. Diabetes 31: 738–741
Scott JE (1987) Proteoglycan histochemistry — a valuable tool for connective tissue biochemists. Coll Rel Res 5: 541–575
Van Kuppevelt THMSM, Rutten TLM, Kuyper CMA (1987) Ultrastructural localization of proteoglycans in tissue using cuprolinic blue according to the critical electrolyte concentration method: comparison with biochemical data from the literature. Histochem J 19: 520–526
Van Kuppevelt THMSM, Domen JGW, Cremers FPM, Kuyper CMA (1984) Staining of proteoglycans in mouse lung alveoli. I. Ultrastructural localization of anionic sites. Histochemical J 16: 657–669
Van Kuppevelt THMSM, Cremers FPM, Domen JGW, Kuyper CMA (1984) Staining of proteoglycans in mouse lung alveoli. II. Characterization of the cuprolinic blue-positive, anionic sites. Histochemical J 16: 671–686
Chakrabarti S, Ma N, Sima AAF (1989) Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-rat. Diabetologia 32: 826–828
McEwen TAJ, Chakrabarti S, Sima AAF (1987) A rapid reproducible method for the determination of basement membrane thickness in biological structure. Comp Biol Med 17: 193–197
Ishibashi T, Tanaka K, Taniguichi Y (1980) Disruption of blood-retinal barrier in experimental diabetic rats: an electron microscopic study. Exp Eye Res 30: 401–410
Sima AAF, Nathaniel V, McEwen TAJ, Bril V, Greene DA (1988) Vascular pathology in diabetic nerve and lack of effect following ARI treatment. Diabetes 37 [Suppl]: 45A
Chakrabarti S, Prashar A, Sima AAF (1990) Augmented polyol pathway activity and retinal pigment epithelium permeability in the diabetic BB-rat. Diab Res Clin Prac 8: 1–12
Klein DJ, Oegema TR Jr, Brown DM (1989) Release of glomerular heparan −35SO 4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Diabetes 38: 130–139
Stow JL, Sanda H, Farquhar GM (1986) Basement membrane heparan sulphate proteoglycans are concentrated in the laminae rarae and podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 82: 3296–3300
Li W, Shen S, Khatami M, Rockey JH (1984) Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high glucose concentration. Diabetes 33: 785–789
King GL, Berman A, Ledbetter S (1988) Regulation of type IV collagen mRNA in retinal capillary endothelial cells and pericytes by glucose levels and aldose inhibitor. Invest Ophthalmol Vis Sci 29 [Suppl]: 181
Polsum R, Kurkinen M, Prockop DJ, Boot-Hanford RP (1988) Increased steady state levels of laminin B1 mRNA in kidneys of long term streptozotocin diabetic rats: no effect of an aldose reductase inhibitor. J Biol Chem 263: 10072–10076
Beyer-Mears A, Murray FT, Cruz E, Rountree J (1990) Ponalrestat, diminution of proteinuria in the BB-rat. Diabetes 39 [Suppl]: 94A (Abstract)
Chandler ML, Shannon WA, DeSantis L (1984) Prevention of retinal capillary basement membrane thickening in diabetic rats by aldose reductase inhibitor. Invest Ophthalmol Vis Sci 25 [Suppl]: 159
Chakrabarti S, Sima AAF, Nakajima T, Yagihashi S, Greene DA (1987) Aldose reductase in the BB-rat: isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 30: 244–251
Ludvigson MA, Sorenson RL (1980) Immunocytochemical localization of aldose reductase. II. Rat eye and kidney. Diabetes 29: 450–459
Terubayashi H, Sato S, Nishimura C, Kador PF, Kinoshita JH (1989) Localization of aldose reductase and aldehyde reductase in the kidney. Kindey Int 36: 843–851
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakrabarti, S., Ma, N. & Sima, A.A.F. Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat. Diabetologia 34, 301–306 (1991). https://doi.org/10.1007/BF00405000
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00405000